Y92-15892-75714
1 vaccination
3 coded responses
5 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 221 / VA
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- 49L-20961-05189
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Moderna
-
2022-06-30
Registered in v-safe
- 2022-06-30
- 2022-07-06
-
2022-07-13
Survey response — day 21, dose 1, under 3MedDRA: Pyrexia, Rhinorrhoea — Feeling: GoodFree text: Fever runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Survey response — day 28, dose 1, under 3MedDRA: Pyrexia — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: FeverMedDRA releases: 2024-11 · check-in free text available
-
2022-07-22
Report sent to call center — day 28, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-07-25
-
2022-07-29
Survey response — day 35, dose 1, under 3MedDRA: Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Report sent to call center — day 35, dose 1, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-01
- 2022-08-01
-
2022-08-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-08-01
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-07-22 | Successful 2022-08-01 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-07-29 | Successful 2022-08-01 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Fever runny nose
Release 12 (Under 3) — day 28, dose 1, under 3
Symptoms: Fever
Release 12 (Under 3) — day 35, dose 1, under 3
Symptoms: Fever and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release